Tumor necrosis factor α: Posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells

Journal of Cellular Physiology

Volumn 166, Issue 3, 1996, Pages 568-576

  Shiohara, Masaaki ^a   Akashi, Makoto ^b   Gombart, Adrian F ^a   Yang, Rong ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MESSENGER RNA; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CDC2-CDC28 KINASES; CELL CYCLE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; CYCLOHEXIMIDE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029928671     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199603)166:3<568::AID-JCP11>3.0.CO;2-3     Document Type: Article

References (53)

1. Akashi, M., Loussararian, A.H., Adelman, D.C., Saito, M., and Koeffler, H.P. (1990) Role of lymphotoxin in expression of interleukin 6 in human fibroblasts: Stimulation and regulation. J. Clin. Invest., 85:121-129.
2. Akashi, M., Shaw, G., Gross, M., Saito, M., and Koeffler, H.P. (1991) Role of AUUUA-sequences in stabilization of granulocytic-macrophage colony-stimulating factor in stimulated cells. Blood, 78:2005-2012.
3. Akashi, M., Shaw, G , Hachiya, M., Elstner, E., Suzuki, G., and Koeffler, P. (1994) Number and location of AUUUA motifs: Role in regulating transiently expressed RNAs. Blood, 83:3182-3187.
4. Baeuerle, P.A., and Baltimore, D. (1988) Activation of DNA-binding activity in an apparently cytoplasrmc precursor of the NF-κB transcription factor. Cell, 53:211-217
5. Bi, S., Huges, T., Bungey, J., Chase, A., de Fabrtiis, P., and Goldman, J.M. (1992) p53 in chronic myeloid leukemia cell lines. Leukemia, 6.839-842.
6. Brewer, G. (1991) An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell Biol., 11.2460-2466.
7. Caput, D., Beutler, B., Thayer, R., Brown-Smith, S., and Cerami, A. (1986) Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. U.S.A., 83:1670-1674.
8. Crook, T , Tidy, J.A., and Vousden, K.H. (1991) Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell, 67:547-556.
9. Dealtry, G.B., Naylor, M.S., Fiers, W., and Balkwill, F.R. (1987) DNA fragmentation and eytotoxicity caused by tumor necrosis factor is enhanced by Interferon-γ. Eur. J. Immunol., 17:689-693.
10. Defilippi, P., Poupart, P., Tavernier, J., Fiers, W., and Content, J. (1987) Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor. Proc. Natl Acad. Sci. U.S.A., 84:4557-4561.
11. El-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A., Burrell, M., Hill, D.E., Wang, Y., Wiman, K.G., Mercer, W.E., Kastan, M.B., Kohn, K.W., Elledge, S.J., Kinzler, K.W., and Vogelstein, B. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54:1169-1174.
12. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75:817-825.
13. Feinberg, A.P., and Vogelstein, B. (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Ann. Biochem., 132:6-13.
14. Fiers, W. (1991) Tumor necrosis factor: Characterization at the molecular, cellular, and in vivo level. FEBS Lett., 285:199-212.
15. Finlay, C.A., Hinds, P.W., and Levine, A.J. (1989) The p53 protooncogene can act as a suppressor of transformation. Cell, 57:1083-1093.
16. Halevy, O., Novitch, B.G., Spieer, D.B., Skapek, S.X., Rhee, J., Hannon, G.J., Beach, D., and Lassar, A B. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science, 267:1018-1021.
17. Hamilton, B.J., Nagy, E., Maler, J.S., Arrick, B.A., and Rigby, W.F.C. (1993) Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J. Biol. Chem., 268:8881-8887.
18. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K, and Elledge, S.J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75:805-816.
19. Hunter, T. (1993) Braking the cycle. Cell, 75:839-841.
20. Israel, A., Le Bail, O., Hatat, D., Piette, J., Kieran, M., Logeat, F., Wallach, D., Fellous, M., and Kourilsky, P. (1989) TNF stimulates expression of mouse MHC class I genes by inducing an NFκB-like enhancer binding activity which displaces constitutive factors. EMBO J., 8:3793-3800.
21. Jiang, H., Lin, J., Su, Z., Collart, F.R., Huberman, E., and Fisher, P.B. (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9:3397-3406.
22. Kastan, M.B., Radin, A.I., Kuerbitz, S.J., Onyekwere, O., Wolkow, C.A., Civin, C.I., Stone, K.D., Woo, T., Ravindranath, Y , and Craig, R.W. (1991) Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res., 51:4279-4286.
23. Koeffler, H.P., Gasson, J., and Tobler, A. (1988) Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol. Cell. Biol., 8:3432-3438.
24. Kolesnick, R., and Golde, D.W. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell, 77:325-328.
25. Laster, S.M., Wood, J.G., and Gooding, L.R. (1988) Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol., 141:2629-2634.
26. Li, R., Waga, S., Hannon, G.J., Beach, D., and Stillman, B. (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature, 371:534-537.
27. Martin, P., and Papayannopoulou, T. (1982) HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin secretion. Science, 216:1233-1235.
28. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M , Sherr, C.J., and Kato, J.Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14:2066-2076.
29. Michieli, P., Chedid, M., Lin, D., Pierce, J.H., Mercer, W.E., and Givol, D. (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54:3391-3395.
30. Munker, R., and Koefner, H.P. (1987) In vitro action of tumor necrosis factor on myeloid leukemic cells. Blood, 69:1102-1108.
31. Nabel, G., and Baltimore, D (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature, 326:711-713.
32. Nakamaki, T., Imamura, J., Brewer, G., Tsuruoka, N., and Koeffler, H.P. (1995) Characterization of AU-rich RNA binding factors. J. Cell. Physiol. (in press).
33. Nawroth, P.P., Bank, I., Handley, D., Cassimeris, J., Chess, L., and Stern, D. (1986) Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J. Exp. Med., 163:1363-1375.
34. Neubauer, A., He, M., Schmidt, C.A., Huhn, D., and Liu, E.T. (1993) Genetic alterations in the p53 gene in the blast crisis of chronic myelogeneous leukemia: Analysis by polymerase chain reaction based techniques. Leukemia, 7:593-600.
35. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetter, R., Cleary, K., Bigner, S.H , Davidson, N , Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modali, R., Hatrris, C.C., and Vogelstein, B. (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature, 342:705-708
36. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M., and Smith, J.R. (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211:90-98.
37. Cip1 in muscle and other terminally differentiating cells. Science, 267:1024-1027.
38. Ponte, P., Gunning, P., Blau, H., and Kedes, L. (1983) Human actin genes are single copy for α-skeletal and α-cardiac actin but multicopy for β- and γ-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol. Cell. Biol., 3:1783-1791.
39. Rubin, B.Y., Anderson, S.L., Sullivan, S.A., and Williamson, B.D. (1986) Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor. J. Exp. Med., 164:1350-1355.
40. Schulze-Osthoff, K., Bakker, A.C., Vanhaesebroeck, B., Beyaert, R., Jacob, W.A., and Fiers, W. (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem., 267:5317-5323.
41. Schwaller, J., Koeffler, H.P., Niklaus, G., Lotscher, P., Nagel, S., El-Deiry, W.S., Vogelstein, B., Fey, M.F., and Tobler, A (1995) The p53-regulated inhibitor of Cdks (PIC1) is expressed and posttranscriptionally regulated in p53-deficient human leukemic cells. J. Clin. Invest., 95:973-979.
42. Shaw, G., and Kamen, R. (1986) A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell, 46:659-667.
43. Shiohara, M., El-Deiry, W.S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D.L., Vogelstein, B., and Koeffler, H.P. (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood, 84:3781-3784.
44. Steinman, R.A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D.A., and El-Houseini, M.E. (1994) Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene, 9:3389-3396.
45. Suffys, P., Beyaert, R., Van Roy, F., and Fiers, W. (1987) Reduced tumor necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism. Biochem. Biophys. Res. Commun., 149.735-743.
46. Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Ishikawa, F., Takaku, F., Yazaki, Y., and Hirai, H. (1992) Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood, 79:2378-2383.
47. Sundstom, C., and Nilsson, K. (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer, 17:565-577.
48. Szekely, L., Selivanaova, G., Magnusson, K.P., Klein, G., and Wiman, K.G. (1993) EBNA-5 an Epstein-Barr virus encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. U.S.A., 90:5455-5459.
49. Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., and Tada, K. (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer, 26:171-176.
50. Wolf, D., and Rotter, V. (1985) Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells Proc. Natl. Acad. Sci. U.S.A., 82:790-794.
51. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature, 366:701-704.
52. Xiong, Y., Zhang, H., and Beach, D. (1992) D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71:505-514.
53. Zhang, H., Hannon, G.J., and Beach, D. (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8:1750-1758.